Skip to main content

Advertisement

Log in

Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease

  • Short Report
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

We evaluated the combined use of different fixatives for the identification of atypical perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in patients with inflammatory bowel diseases (IBD) by indirect immunofluorescence (IIF). Sera from 59 ulcerative colitis (UC) and 37 Crohn’s disease (CD) patients, and from 64 healthy controls were studied. The IIF on ethanol-, formalin-, and methanol-fixed neutrophils was used for the detection of ANCA. Enzyme linked immunosorbant assay (ELISA) was performed to identify the antigens recognized by ANCA. ANCAs were present in 35 of 59 (59.3%) UC patients and in 10 of 37 (27.02%) CD patients. Atypical p-ANCA positivity was strongly associated with UC disease (44.1% in UC vs. 8.1% in CD; p = 0.0002). The combined application of different fixatives contributed to make easy the differentiation between typical p-ANCA and atypical p-ANCA. Atypical p-ANCA determination appears to be a useful parameter for the distinction between UC and CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.

    Article  PubMed  CAS  Google Scholar 

  2. Desplat-Jégo S, Johanet C, Escande A, et al. Update on anti-Saccharomyces cerevisiae, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study. World J Gastroenterol. 2007;13:2312–8.

    PubMed  Google Scholar 

  3. Anand V, Russell AS, Tsuyuki R, Fedorak R. Perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn’s disease and ulcerative colitis. Can J Gasteroenterol. 2008;22:33–6.

    Google Scholar 

  4. Savige J, Gillis D, Benson E, et al. International consensus statement on testing and reporting of anti-neutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 1999;111:507–13.

    PubMed  CAS  Google Scholar 

  5. Terjung B, Worman HJ, Herzog V, Sauerbruch T, Spengler U. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin Exp Immunol. 2001;126:37–46.

    Article  PubMed  CAS  Google Scholar 

  6. Silverberg MS, Satsangi J, Ahmed T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Monteral World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A:5–36.

    PubMed  Google Scholar 

  7. Klebl FH, Bataille F, Bertea CR, et al. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Sacchaomyces cerevisiae antibodies with Vienna classification subtypes of Crohn’s disease. Inflamm Bowel Dis. 2003;9:302–7.

    Article  PubMed  Google Scholar 

  8. Frenzer A, Fierz W, Rundler E, Hammer B, Binek J. Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 1998;13:863–4.

    Article  Google Scholar 

  9. Freeman H, Roeck B, Devine D, Carter C. Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease. Can J Gastroenterol. 1997;11:203–7.

    PubMed  CAS  Google Scholar 

  10. Sugi K, Saitoh O, Matsuse R, et al. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Am J Gastroenterol. 1999;94:1304–12.

    Article  PubMed  CAS  Google Scholar 

  11. Radice A, Vecchi M, Bianchi MB, Sinico RA. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin Exp Rheumatol. 2000;18:707–12.

    PubMed  CAS  Google Scholar 

  12. Perri F, Annese V, Piepoli A, et al. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol. 1998;30:56–61.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Ministère de la recherché Scientifique et de la Technologie (MRST), Tunisia. We thank Mrs Samia Boukthir for her excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dorra Bouzid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bouzid, D., Haddouk, S., Amouri, A. et al. Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Indian J Gastroenterol 30, 229–232 (2011). https://doi.org/10.1007/s12664-011-0127-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-011-0127-3

Keywords

Navigation